Stock AGN AEGON LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aegon Ltd. London S.E.

Equities

AGN

BMG0112X1056

Life & Health Insurance

Market Closed - London S.E.
Other stock markets
 16:30:00 28/06/2024 BST 		5-day change 1st Jan Change
5.816 EUR -0.80% Intraday chart for Aegon Ltd. -1.73% +10.67%
06-25 Transcript : Aegon Ltd. - Special Call
06-12 Transcript : Aegon Ltd. - Shareholder/Analyst Call

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,056 6,538 8,826 9,141 8,212 10,105 - -
Enterprise Value (EV) 1 7,443 -1,834 13,792 12,080 8,738 21,777 12,056 12,056
P/E ratio 5.28 x 162 x 5.49 x -3.79 x -43.7 x 7.97 x 6.97 x 6.64 x
Yield 7.62% 3.71% 3.87% 4.85% 5.72% 6.17% 6.93% 7.41%
Capitalization / Revenue 0.44 x 0.41 x 0.57 x 0.62 x - 0.78 x 0.71 x 0.7 x
EV / Revenue 0.41 x -0.11 x 0.89 x 0.82 x - 1.68 x 0.85 x 0.84 x
EV / EBITDA - - - - - - - -
EV / FCF 1.03 x -3.8 x 18.9 x 15.5 x 12.2 x 28.5 x 14.5 x 12.2 x
FCF Yield 96.7% -26.3% 5.29% 6.46% 8.18% 3.51% 6.91% 8.19%
Price to Book 0.36 x 0.29 x 0.37 x 0.83 x 1.23 x 1.04 x 0.98 x 0.93 x
Nbr of stocks (in thousands) 1,980,832 2,021,164 2,009,073 1,929,320 1,564,872 1,751,952 - -
Reference price 2 4.067 3.235 4.393 4.738 5.248 5.768 5.768 5.768
Announcement Date 13/02/20 11/02/21 09/02/22 09/02/23 01/03/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 18,138 16,099 15,444 14,761 - 12,937 14,148 14,369
EBITDA - - - - - - - -
EBIT 1 1,973 1,729 1,906 1,918 1,498 1,632 1,673 1,760
Operating Margin 10.88% 10.74% 12.34% 12.99% - 12.61% 11.82% 12.25%
Earnings before Tax (EBT) 1 1,872 -84 2,056 -2,319 -317 1,591 1,743 1,882
Net income 1 1,528 55 1,651 -2,533 -247 1,187 1,309 1,304
Net margin 8.42% 0.34% 10.69% -17.16% - 9.17% 9.25% 9.08%
EPS 2 0.7700 0.0200 0.8000 -1.250 -0.1200 0.7234 0.8281 0.8683
Free Cash Flow 1 7,200 482 729 780 715 764.5 833.7 988
FCF margin 39.7% 2.99% 4.72% 5.28% - 5.91% 5.89% 6.88%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 471.2% 876.36% 44.16% - - 64.43% 63.69% 75.76%
Dividend per Share 2 0.3100 0.1200 0.1700 0.2300 0.3000 0.3557 0.4000 0.4275
Announcement Date 13/02/20 11/02/21 09/02/22 09/02/23 01/03/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 S1 2023 Q4 2023 S2 2024 S1 2024 S2
Net sales - - - - 3,662 3,915 - 6,188 3,651 3,577 - - - - - -
EBITDA - - - - - - - - - - - - - - - -
EBIT - 710 - - 443 470 463 538 429 488 - - - - 763 788
Operating Margin - - - - 12.1% 12.01% - 8.69% 11.75% 13.64% - - - - - -
Earnings before Tax (EBT) 1,105 111 -195 - -107 627 394 -454 -300 -1,978 - - - - 557 551
Net income 910 202 - - -60 504 385 -365 -200 -2,352 - - - - 417 411
Net margin - - - - -1.64% 12.87% - -5.9% -5.48% -65.75% - - - - - -
EPS 0.4500 0.0800 - - -0.0400 0.2500 0.1900 -0.1900 -0.1000 -1.180 - - - - 0.2500 0.2600
Dividend per Share 1 0.1600 0.0600 0.0600 0.0800 - 0.0900 - 0.1100 - 0.1200 0.1400 0.1400 0.1600 0.1600 0.1800 0.1800
Announcement Date 13/02/20 13/08/20 11/02/21 12/08/21 11/11/21 09/02/22 12/05/22 11/08/22 10/11/22 09/02/23 01/09/23 - 01/03/24 01/03/24 - -
1EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 4,966 2,939 526 11,672 1,951 1,951
Net Cash position 1 613 8,372 - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 7,200 482 729 780 715 765 834 988
ROE (net income / shareholders' equity) 9.6% 8.5% 6.35% -14.2% 14.7% 12.5% 12.2% 12.6%
ROA (Net income/ Total Assets) 0.37% 0.32% 0.34% 0.34% - 0.3% 0.33% 0.34%
Assets 1 417,065 17,405 492,395 -736,337 - 392,908 400,890 381,323
Book Value Per Share 2 11.20 11.10 11.90 5.740 4.270 5.550 5.900 6.230
Cash Flow per Share 3.580 -1.390 -0.8700 - - - - -
Capex 1 - 80 - - - 180 177 175
Capex / Sales - 0.5% - - - 1.39% 1.25% 1.22%
Announcement Date 13/02/20 11/02/21 09/02/22 09/02/23 01/03/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Aegon Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
5.768 EUR
Average target price
6.097 EUR
Spread / Average Target
+5.71%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Life & Health Insurance

1st Jan change Capi.
AXA Stock AXA
+3.66% 72.1B
AFLAC INCORPORATED Stock Aflac Incorporated
+8.25% 50.75B
METLIFE, INC. Stock MetLife, Inc.
+6.14% 49.91B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+24.42% 47.64B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+13.00% 42.08B
GENERALI Stock Generali
+21.91% 38.54B
CHINA PACIFIC INSURANCE (GROUP) CO., LTD. Stock China Pacific Insurance (Group) Co., Ltd.
+17.16% 33.02B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
-2.39% 28.42B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-9.01% 27.19B
Other Life & Health Insurance
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. AGN Stock
  5. Financials Aegon Ltd.